Page 118 - Assurance of Sterility for Sensitive Combination Products and Materials
P. 118

102   Assurance of sterility for sensitive combination products and materials


          world. DuPont supported their customers by gaining alignment with the
          regulatory bodies which included providing data with multiple methodol-
          ogies to support the change assessments and notifications.

          5.3.3.5  Validation of test methods
          Validation of packaging test methods has been a subject of intense discus-
          sion in the medical device industry since the introduction of ISO 11607
          “Packaging for terminally sterilized medical devices” in 2006. Unlike the medical
          device industry, the pharmaceutical industry has diligently embraced the con-
          cept of validation in analytical procedures for identification, and quantifica-
          tion of impurities and active ingredients. US and European pharmaceutical
          products regulatory requirements are captured as a part of good manufactur-
          ing practice (GMP) (US: 21CFR211.165, EU: Volume 4 EU Guidelines to
          Good Manufacturing Practice [62], guidance in ICH Q2(R1) [63] accepted
          by the FDA, EU, and Japan). The purpose of validation is to provide docu-
          mented evidence to demonstrate that a method fulfills the requirements for
          its intended use, in other words, that it is suitable for its intended use.
             The ASTM made significant contributions in the area of test method
          validation with its rigorous approach for conducting interlaboratory studies
          to determine the precision and bias of a test method (see ASTM E691 [64])
          The precision is determined by establishing the repeatability or the variabil-
          ity between measurements produced by the same equipment and operator,
          respectively, the reproducibility or the variability between measurements
          between different test equipment, operators, and/or test laboratories. The
          precision and bias section, included in each standard, gives an indication
          about the limits of detection of the method as well as the typical variability,
          which is required when selecting adequate test methods and when imple-
          menting the test method in a laboratory.
             Test method selection, implementation, validation can be onerous tasks
          and it is important to keep the identified risk to the patient in mind in
          relation to packaging design aspects to be assessed. Validation should cover
          limits for the intended application and not the method’s theoretical capa-
          bility. Guidance for SBS test method validation can be found in annex O
          of ISO TS 16775 [38]. General principles and definitions are available in
          ISO 5725-1 [65], a basic method for the determination of repeatability and
          reproducibility is proposed in ISO 5725-2 [66].

          5.3.4  Design validation
          Design validation and process validation of a specified SBS are two dis-
          tinct activities, although they are done together. Design validation includes
   113   114   115   116   117   118   119   120   121   122   123